Skip to main content

Casamento Charles J's Form 4 filing

Relmada Therapeutics, Inc. (RLMD) · filed Sep 24, 2021

Accession no.
0001213900-21-049820
Filed
Sep 24, 2021
Trade date
Sep 22, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $191.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Casamento Charles JCIK 0001117167Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 22, 2021Common StockMOption exerciseAcquired+10,000$4.60+$46,00016,600Direct
Sep 22, 2021Common StockSSaleDisposed−1,900$29.00−$55,10014,700Direct
Sep 22, 2021Common StockSSaleDisposed−3,300$29.00−$95,70011,400Direct
Sep 22, 2021Common StockSSaleDisposed−1,400$29.00−$40,60010,000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 22, 2021Common StockMOption exerciseDisposed−1,900$0.00F3$097,311Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

Not applicable

Referenced by the price of 1 transaction in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)